The role of endogenous testosterone(T) in mediating hypertrophic responses to resistance exercise training(RET) remains contentious with correlative studies suggesting a limited role1, and others a more central role2. We thus investigated the physiological and mechanistic effects of chemical endogenous T depletion adjuvant to 6-wk of RET on muscle mass, function, myogenic regulatory factors and muscle anabolic signalling, protein synthesis and glycaemic control in younger men. Sixteen non-hypogonadal healthy young men (18-30y, BMI≤30kg.m-2, serum T>230 ng.dl-1) were randomised in a double-blinded fashion to receive either: placebo (P, saline n=8) or the GnRH analogue, Goserelin (Zoladex (Z) (3.6-mg, n=8)) injections before undertaking 6-wks of RET(6-exercises,3-sets,8-10-reps,80% 1-RM). Participants underwent Dual-energy X-ray Absorptiometry, ultrasound of m.vastus lateralis (VL) and Oral Glucose Tolerance Testing; finally, m.vastus biopsies were taken to quantify myogenic gene expression, anabolic pathways and muscle protein synthesis (MPS) and break down rates (MPB). Provision of Z during RET suppressed endogenous T (Z:45.2±4, vs. P:323±30 ng.dl-1, P<0.001). The Z group exhibited blunted whole-body (Z:55±3 to 56±3, P=0.6 vs. P:56±2 to 58±2kg, P=0.006), appendicular (Z:8.2±0.3 to 8.4±0.4, P>0.9 vs. P:7.6±0.3 to 8.3±0.3kg.m-2, P=0.07), and VL (Z:0.01±0.01 vs. P:6.2±1.1%, P=0.007) lean mass gains, and composite strength gains (Z:40±2 vs. P:50±3%, P=0.03). Reductions in body fat percentage were only evident in the P group (Z:23±2 to 24±2%, P=0.2 vs. P:24±3 to 23±3%, P=0.04). The P group exhibited augmented gene expression related to T metabolism (e.g. Androgen Receptor: 1.8-fold; HSD17B3: 2.8-fold, P<0.05); anabolism/myogenesis (e.g. IGF-1EA (3.3-fold), Myogenin (2.6-fold), Myf5 (2.6-fold), c-Met (2.7-fold), P<0.05) in addition to RNA/DNA (P:0.5±0.1 to 0.6±0.1, P=0.0003 vs. Z:0.5±0.1 to 0.5±0.1, P=0.3), and RNA/ASP ratio (P:6.5±0.2 to 8.9±1.1, P=0.008 vs. Z:5.8±0.4 to 6.8±0.5, P>0.9). Also, acute RET-induced phosphorylation of AKTser473 (Z:4.9±1.6-fold, P=0.7 vs. P:10.1±5.3-fold, P=0.003) and mTORC1ser2448 (Z:2.5±1.3-fold, P>0.9 vs. P:4.8±2.1-fold, P=0.03) were attenuated in the Z group. Both MPS (P:2.01±0.1 vs. Z:1.54±0.1%.day−1, P=0.01) and MPB rates (P:129.1±13 vs. Z:93.1±7.8 g.day-1, P=0.04) were higher in P group, which led to higher net turnover and protein accretion (P:3.9±1.1 vs. Z:1.2±1.1 g.day-1, P=0.04). Only the P group enhanced insulin sensitivity (Cederholm: P:14.5±4.9 vs. Z:2.1±0.4 mg.L2.mmol.L−1.mU−1.min−1, P=0.04). Chemical T depletion during RET blunted muscle insulin/anabolic signalling, T processing enzyme and pro-myogenic gene expression, perhaps explaining attenuated muscle growth and insulin sensitivity in this group. Thus, decreasing endogenous levels of T coupled to RET attenuates numerous positive adaptations to RET – thereby, demonstrating the, at least, permissive importance of endogenous T in regulating muscle hypertrophy.
Physiology 2019 (Aberdeen, UK) (2019) Proc Physiol Soc 43, PC119
Poster Communications: Pharmaceutical endogenous testosterone depletion blunts resistance exercise-induced hypertrophy in younger men via impairing muscle growth programming
N. Gharahdaghi1, S. Rudrappa1, B. Phillips1, M. S. Brook1, W. F. Farrash1, M. Aziz1, I. Idris1, P. J. Herrod1, T. Sian1, D. J. Wilkinson1, N. J. Szewczyk1, K. Smith1, P. J. Atherton1
1. Medical Sciences & Graduate Entry Medicine, University of Nottingham, Derby, United Kingdom.
View other abstracts by:
Where applicable, experiments conform with Society ethical requirements.